Optimus Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is AMINOCAPROIC ACID, with a corresponding US DMF Number 33407.
Remarkably, this DMF maintains an Active status since its submission on December 19, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 21, 2019, and payment made on December 11, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II